BiotechTube

Vadadustat

Phase 3Withdrawn
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anemia of Chronic Kidney Disease

Conditions

Anemia of Chronic Kidney Disease

Trial Timeline

Jan 1, 2025 → Oct 1, 2026

NCT ID
NCT05082584

About Vadadustat

Vadadustat is a phase 3 stage product being developed by Akebia Therapeutics for Anemia of Chronic Kidney Disease. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT05082584. Target conditions include Anemia of Chronic Kidney Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (5)

NCT IDPhaseStatus
NCT05082584Phase 3Withdrawn
NCT05082571Phase 3Withdrawn
NCT03657290Phase 1Completed
NCT03799848Phase 1Completed
NCT04707573Phase 2Completed

Competing Products

20 competing products in Anemia of Chronic Kidney Disease

See all competitors
ProductCompanyStageHype Score
Aranesp®AmgenApproved
84
KER-047Keros TherapeuticsPhase 2
44
LY2787106Eli LillyPhase 1
33
R744 + R744Chugai PharmaceuticalPhase 3
77
epoetin beta + placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietin placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietinChugai PharmaceuticalPhase 3
77
darbepoetin alfaAmgenPhase 3
76
PrasugrelDaiichi SankyoPhase 1
33
Prasugrel + PlaceboDaiichi SankyoPhase 2
52
roxadustatAstellas PharmaPhase 3
77
roxadustatAstellas PharmaPhase 3
77
Roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77
AlefaceptAstellas PharmaPhase 1
33
RoxadustatAstellas PharmaPhase 2
52
roxadustatAstellas PharmaPhase 1
33
Roxadustat + PlaceboAstellas PharmaPhase 3
77
RoxadustatAstellas PharmaPre-clinical
23
Roxadustat + Epoetin AlfaAstellas PharmaPhase 3
77
roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77

Other Products from Akebia Therapeutics

Ferric Citrate 1 gram Oral Tablet + Standard of care phosphate-lowering therapyApproved
77
Vadadustat + Darbepoetin alfaPhase 3
69
Vadadustat + Darbepoetin alfaPhase 3
69
Vadadustat + Darbepoetin alfaPhase 3
69
Ferric Citrate 1 GM Oral Tablet [AURYXIA] + PlaceboPhase 3
69